Cargando…
Converging multi-modality datasets to build efficient drug repositioning pipelines against Alzheimer’s disease and related dementias
Alzheimer’s disease and related dementias (AD/ADRD) affects more than 50 million people worldwide but there is no clear therapeutic option affordable for the general patient population. Recently, drug repositioning studies featuring collaborations between academic institutes, medical centers, and ho...
Autores principales: | Yin, Zheng, Wong, Stephen T.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
De Gruyter
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047641/ https://www.ncbi.nlm.nih.gov/pubmed/35658114 http://dx.doi.org/10.1515/mr-2021-0017 |
Ejemplares similares
-
On the horizon—the value and promise of the global pipeline of Alzheimer's disease therapeutics
por: Cole, Michael A., et al.
Publicado: (2020) -
Building a Pipeline to Increase Academic Workforce Diversity to Achieve Health Equity
por: Jean-Louis, Girardin
Publicado: (2021) -
Active immunotherapy and alternative therapeutic modalities for Alzheimer's disease
por: Weninger, Stacie, et al.
Publicado: (2020) -
The therapeutic potential of mesenchymal stem cells in Alzheimer's disease: converging mechanisms
por: Turgeman, Gadi
Publicado: (2015) -
Repositioning imatinib for spinal cord injury
por: Kjell, Jacob, et al.
Publicado: (2015)